Cargando…
Update on subcutaneous methotrexate for inflammatory arthritis and psoriasis
Methotrexate (MTX) is one of the mainstays of treatment for several immune-mediated inflammatory joint and skin diseases, especially rheumatoid arthritis (RA) and moderate-to-severe psoriasis. Oral MTX has been used for the treatment of such diseases for decades for many reasons. There is, however,...
Autores principales: | Vena, Gino Antonio, Cassano, Nicoletta, Iannone, Florenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767093/ https://www.ncbi.nlm.nih.gov/pubmed/29386902 http://dx.doi.org/10.2147/TCRM.S154745 |
Ejemplares similares
-
Drug focus: adalimumab in the treatment of moderate to severe psoriasis
por: Vena, Gino A, et al.
Publicado: (2007) -
Psoriasis in pregnancy: challenges and solutions
por: Vena, Gino Antonio, et al.
Publicado: (2015) -
Pustular Psoriasis: From Pathophysiology to Treatment
por: Genovese, Giovanni, et al.
Publicado: (2021) -
The Intriguing Links between Psoriasis and Bullous Pemphigoid
por: Maronese, Carlo Alberto, et al.
Publicado: (2022) -
Subcutaneously-Administered Infliximab in the Management of Rheumatoid Arthritis: A Short Narrative Review of Current Clinical Evidence
por: Iannone, Florenzo, et al.
Publicado: (2022)